Salarius Pharmaceuticals Inc. (SLRX) |
|
0.9481 -0.092 (-8.84%)
|
02-21 16:00 |
|
Open: |
1.05 |
Pre. Close: |
1.04 |
|
High:
|
1.05 |
Low:
|
0.9215 |
|
Volume:
|
728,955 |
Market Cap:
|
12M |
|
|
|
|
Salarius Pharmaceuticals, Inc. a clinical-stage oncology company, develops therapies for the treatment of patients with various cancers. The company's lead candidate is Seclidemstat, which is in clinical development for the treatment of Ewing sarcoma, as well as advanced solid tumors, including prostate, breast, and ovarian cancers. It has a collaborative partnership with The Ivy Brain Tumor Center at the Barrow Neurological Institute to to develop cancer treatment for glioblastoma. Salarius Pharmaceuticals, Inc. is headquartered in Houston, Texas. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.051 - 1.056 |
1.056 - 1.06 |
|
Low:
|
0.909 - 0.914 |
0.914 - 0.918 |
|
Close:
|
0.942 - 0.95 |
0.95 - 0.957 |
|
Technical analysis |
as of: 2020-02-21 4:33:54 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 2.62 One year: 3.69 |
| Support: |
Support1: 0.75 Support2: 0.62 |
| Resistance: |
Resistance1: 2.24 Resistance2: 3.16 |
| Pivot: |
1.36 |
| Moving Average: |
MA(5): 0.95  MA(20): 1.69
MA(100): 3.74 MA(250): 7.80 |
| MACD: |
MACD(12,26): -0.62 Signal(9): -0.61 |
| Stochastic oscillator: |
%K(14,3): 11.13 %D(3): 9.42 |
| RSI: |
RSI(14): 24.50 |
| 52-week: |
High: 24.45 Low: 0.75 Change(%): -88.5 |
| Average Vol(K): |
3-Month: 25531 10-Days: 109835 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.SLRX has closed above bottom band by 34.4%. Bollinger Bands are 80.6% wider than normal. The large width of the bands suggest high volatility as compared to SLRX's normal range. The bands have been in this wide range for 8 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Fri, 07 Feb 2020 20:54:37 +0000
Health Care Sector Update for 02/07/2020: LGND,ASRT,COLL,SLRX
Fri, 07 Feb 2020 18:42:03 +0000
Health Care Sector Update for 02/07/2020: LGND,ASRT,COLL,SLRX
Mon, 26 Aug 2019 17:41:57 +0000
Health Care Sector Update for 08/26/2019: RKDA, SLRX
Mon, 26 Aug 2019 19:57:35 +0000
Health Care Sector Update for 08/26/2019: AKRX, RKDA, SLRX
Wed, 14 Mar 2018 07:14:36 +0000
5 ‘Strong Buy’ Biotechs That Can Double in 2018
|
Financial Analysis |
| Growth |
NA |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
NA |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NasdaqCM |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
12.86 |
| Shares Float (M) |
2.93 |
|
% Held by Insiders
|
9.26 |
|
% Held by Institutions
|
1.74 |
|
Shares Short (K)
|
106 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-5.136 |
|
Book Value (p.s.)
|
2.590 |
|
PEG Ratio
|
|
|
Profit Margin
|
-200.50 |
|
Operating Margin
|
-148.62 |
|
Return on Assets (ttm)
|
-27.2 |
|
Return on Equity (ttm)
|
-109.7 |
|
Qtrly Rev. Growth
|
86.5 |
|
Gross Profit (p.s.)
|
0.052 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-0.353 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-8.56 |
|
Levered Free Cash Flow (M)
|
-2.95 |
Stock Valuations |
|
P/E
|
-0.18 |
|
P/E Growth Ratio
|
-0.09 |
|
P/BV
|
0.37 |
|
P/S
|
0.37 |
|
P/CF
|
-1.42 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
2019-07-21 |
|
Last Split Ratio
|
0.04 |
|
7 Binary Options
|
|
Your Ad Here
|
|
